Professor, Senior Consultant
St. Erik Eye Hospital and Karolinska Institutet, Stockholm
Gustav Stålhammar is Professor at Karolinska Institutet and Senior Consultant Ophthalmologist at St. Erik Eye Hospital in Stockholm, where he heads the Ophthalmic Pathology Laboratory. He is board-certified in both ophthalmology and clinical pathology and is a Fellow of the European Board of Ophthalmology (FEBO).
Gustav leads the highly specialised Ocular Oncology and Pathology research group, focusing on uveal melanoma and retinoblastoma, with particular interest in early detection, prognostics, and innovative treatment strategies. His work combines clinical ophthalmology, pathology, and advanced technology to improve diagnostics and outcomes for patients with ocular tumours.
His group currently runs the world’s longest ongoing randomised clinical trial of adjuvant melatonin in uveal melanoma and has also developed a deep learning algorithm designed to distinguish benign pigmented fundus lesions from melanoma.
